Investing
First Look Analyst Calls Briefing for Monday, October 31, 2022
Published:
Last Updated:
This report was sent to Briefing.com subscribers earlier today.
> BioMarin Pharmaceutical (BMRN) upgraded to Outperform from Perform at Oppenheimer; tgt raised to $110
> Cullen/Frost (CFR) upgraded to In-line from Underperform at Evercore ISI; tgt raised to $160
> ABB Ltd (ABB) downgraded to Buy from Conviction Buy at Goldman
> Advanced Micro (AMD) downgraded to Market Perform from Outperform at Northland Capital; tgt lowered to $60
> Ameris Bancorp (ABCB) downgraded to Mkt Perform from Outperform at Raymond James
> Aon (AON) downgraded to Underperform from Mkt Perform at Raymond James
> Ares Commercial Real Estate (ACRE) resumed with a Buy at BofA Securities; tgt $13
> Business First Bancshares (BFST) initiated with an Outperform at Raymond James; tgt $28
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.